CSBR
Champions Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.11
−3.22%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
46.5x
EV/EBITDA
158.4x
Market Cap
$71.12M
MomentumView details →
1D Return
−3.22%
YTD Return
−26.92%
RSI (14)
45.2
ValuationView details →
P/E (Fwd)
46.5x
EV/EBITDA
158.4x
Market Cap
$71.12M
RSI (14)
45.2
MomentumView details →
1D Return
−3.22%
YTD Return
−26.92%
SummaryUpdated Apr 1, 2026
Champions Oncology, Inc. (NASDAQ:CSBR) is a biotechnology company founded in 1985 and headquartered in Hackensack, New Jersey. Originally incorporated as Champions Biotechnology, the company changed its name to Champions Oncology in April 2011 to better reflect its focus on cancer research. The company has been publicly traded since its IPO in February 2007. Champions Oncology specializes in developing personalized cancer research solutions and technology platforms that help pharmaceutical and biotechnology companies advance their oncology drug development programs.
Similar companies
Latest newsMore news →